| abstract |
The vaccine is prepared by mixing a reo virus containing liquid, obtained by cultivation of a reo virus, followed by inactivation of this liquid and optionally homogenising it, with a adeno like virus (ALV) containing liquid, obtained by cultivation of an ALV, followed by inactivation of this liquid and optionally homogenising it, and adding the mixture to an oily phase containing as essential components at least one of the components selected from the group consisting of light mineral paraffenic oils, plant oils and naphtenic mineral oils, and one or more emulsifiers, such as non-ionic surface-active compounds derived from alkylene oxide and/or hexahydric alcohols and/or higher natural fatty acids such as esters or ester-ethers optionally followed by homogenising and/or addition of a preservative. |